Nalbuphine Can Relieve Opioid-Induced Urine Retention

Share this content:
Nalbuphine Can Relieve Opioid-Induced Urine Retention
Nalbuphine Can Relieve Opioid-Induced Urine Retention

TUESDAY, Sept. 4, 2018 (HealthDay News) -- Nalbuphine can relieve opioid-induced urine retention, according to a case report published online Sept. 4 in the Annals of Internal Medicine.

Abdisamad M. Ibrahim, M.D., from the Southern Illinois University School of Medicine in Springfield, and colleagues describe how nalbuphine helped manage opioid-induced urine retention in a 59-year-old man with a history of alcoholic cirrhosis who was hospitalized for worsening right-sided abdominal pain. The patient was diagnosed with portal vein thrombosis and hepatocellular carcinoma.

The authors note that after treatment of pain with hydromorphone, the patient developed new-onset urine retention that did not respond to α1-blockers and required intermittent urinary catheterization. The patient found the intervention inconvenient and declined placement of a permanent catheter. A literature search revealed use of nalbuphine for reversal of postoperative urine retention without loss of pain control. The patient consented to this treatment, and 10 mg nalbuphine was administered intravenously. During the first six hours after receiving the drug, the patient voided 850 mL, and pain remained controlled. On ultrasonography, bladder volume was 77 mL one day later. The patient required no additional nalbuphine treatment before being discharged to hospice the next day.

"We believe that clinicians should consider offering nalbuphine to patients with opioid-induced urine retention that does not respond to α1-blockers who prefer to stop bladder catheterization," the authors write.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA: Gout Drug Uloric Increases Risk of Death

FDA: Gout Drug Uloric Increases Risk of Death

Medication is associated with increased risk of heart-related death and death from all causes

Since Early 2000s, Overdose Death Rates Are Highest in U.S.

Since Early 2000s, Overdose Death Rates Are Highest ...

U.S. was not an outlier in terms of drug overdose mortality prior to the early 2000s

National Health Spending Set to Increase 5.5 Percent Annually

National Health Spending Set to Increase 5.5 Percent ...

Long-observed demographic and economic factors expected to drive growth in health spending

is free, fast, and customized just for you!




Already a member?

Sign In Now »